Page 107 - DiaCare

107

‫منابع‬

1. A. Esteghamati, B. Larijani, M. Haji Aghajani, F. Ghaemi, J. Kermanchi, A. Shahrami, M. Saadat, E. Nasli Esfahani, M. Ganji, S.
Noshad, E. Khajeh, A. Ghajar, B. Heidari, M. Afarideh, J.I. Mechanick & F. Ismail-Beigi. Diabetes in Iran: prospective analysis from
first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci. Rep. 7, 1–10
(2017).

2. S. Moradi, H. Baradaran, Prevalence of retinopathy and microalbuminuria in people with type 2 diabetes at Tehran Institute of
Endocrine and Metabolism, Iran, Diabet. Med. 23 (Suppl. 4) (2006) 181.

3. E. Faghih-Imani, M. Amini, P. Adibi, Silent ischemia in type II diabetic patients: a study of EKG changes, ARYA J. 1 (2005) 89–93.

4. D. Aghadoost, F. Sadr, Prevalence and risk factors for diabetic retinopathy in diabetic patients in Kashan Diabetes Centre in
2002–2003 (Farsi), Feyz 33 (2005) 62–65.

5. A.S. Habibi Moeini, L. Navaei, F. Azizi, Micro- and macrovascular diabetic complications in NIDDM: a population-based, case-
control study (Farsi), Iranian Endo. Metab. J. 1 (1999) 38–47.

6. M.R. Manaviat, M. Afkhami, Study on the rate of presence of retinopathy in diabetic type II patients referring to the Yazd diabetic
centre (Farsi), Med. J. Yazd Univ. Med. Sci. 10 (2003) 41– 46.

7. M.R. Manaviat, M. Afkhami, M.R. Shoja, Retinopathy and microalbuminuria in type II diabetic patients, B. M. C. Ophthalmol. 4
(2004) 9.

8. B. Larijani, E. Javadi, A. Shafaee, M. Mahmoudi, R. Baradar- Jalilli, P. Hemati, Screening for microalbuminuria in the early detection
of diabetic nephropathy: a cheap and simple method, Acta Med. Iran. 40 (2002) 65–68.

9. M. Shakiba, M. Afkahmi Ardakani, A.M. Orfa, Prevalence of micro- and macroalbuminuria in type 2 diabetic patients referred to
Yazd Diabetes Research Centre (Farsi), Med. J. Yazd Univ. Med. Sci. 10 (2003) 20–24.

10. M. Janghorbani, H. Rezvanian, A. Kachooei, A. Ghorbani, A. Chitsuz, F. Izadi, et al., Peripheral neuropathy in type 2 diabetes
mellitus in Isfahan, Iran: prevalence and risk factors, Acta Neurol. Scand. 114 (2006) 384–391.

11. IMI d.Hia.bKehtaezsa: ia, B. Khazai, Z. Zargaran, Z. Moosavi, F. Khadivi Zand, Diabetic complications and risk factors in recently diagnosed type
case-control study, ARYA J. 2 (2006) 79–83.

12. A. Alavi, M. Sanjari, A. Haghdoost, R.G. Sibbald, Diabetic foot ulcers in Kerman, Iran: prospective, descriptive review, Wound Rep.
Reg. 15 (2007) A47.

13. E. Faghih-Imani, M. Amini, P. Adibi, Silent ischemia in type II diabetic patients: a study of EKG changes, ARYA J. 1 (2005) 89–93.

14. HEn. dSoaf.aMeie, tMab..AJm. 8in(i2,0J.0B6e) h3r1o–o3z8,.Cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus (Farsi), Iran.

15. N. Amini, S. Oroumcheh, F. Taghavi, Prevalence of hypertension among 780 diabetic patients referred to Yazd Diabetes Centre in
2002–2003 [Dissertation], Yazd University of Medical Sciences, Yazd (YZD), 1993, 55 p.

16. M. Janghorbani, M. Amini, A. Tavassoli, Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk
factors, Acta Cardiol. 61 (2006) 13–20.

17. NWohsehraedWe S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes Care in Iran:
Stand and Where We Are Headed. Ann Glob Health. 2015 Nov-Dec;81(6):839-50.

18. Y. Jahangiri-Noudeh, S. Akbarpour, M. Lotfaliany, et al.Trends in cardiovascular disease risk factors in people with and without
diabetes mellitus: a Middle Eastern cohort study.PLoS One,9 (2014), p. e112639.

19. Esteghamati A, Etemad K, Koohpayehzadeh J, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association
with obesity in Iran: 2005-2011. Diabetes Res Clin Pract 2014;103: 319e27.

20. sSearriaeysaanni dA,bReanschhimdiaanrkAin,gGshtuodlaym. Bi MK.JLOowpeunti2li0s1at4i;o4n:eo0f 0d5ia8b5e9t.es medicines in Iran, despite their affordability (2000e2012): a time-

21. International Society for Pharmocoepidemiology, April 2007. ‘Guidelines for Good Pharmacoepidemiology Practices’.

22. Good Epidemiological Practice (GEP) proper conduct in epidemiology research – IEA European Federation (April 2007).

23. Ffuotrudree,leCa.r;nS.ccoomrin/guptlhoeadIsn/tfeilrensa/tbioc/nca5l/Pbhccy5si3cba1l 4A-cetciv1iety-4dQ9u0e-s8t8ioen3n-1a5ir6e8(6I8PA2Qf3)2.aUen/IiPvA. QD_uPbDlinF.. 2018. Available online: https://ugc.

24. . Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-
MD 1000 study. JAMA.1994;272:1749-1756.

25. Ali Montazeri A, Vahdaninia M, Mousavi S. J , Omidvari S. The Iranian version of 12-item Short Form Health Survey (SF-12): factor
structure, internal consistency and construct validity. BMC Public Health. 2009; 9: 341.

26. D20e0la9v;a1r2i:A49, 2A–li5k.hani S, Nili S, Birjandi RH, Birjandi F. Quality of care of diabetes mellitus type II patients in Iran. Arch Iranian Med.

27. Fox KM, Gerber RA, Bolinder B, Chen J, Kumar S. Prevalence of inadequate Glycemic control among patients with diabetes in the
United Kingdom general practice research data base: a series of retrospective analysis of data from 1998–2002. Clinl Ther. 2006;
28: 388–95.

28. Alvarez Guisasola F, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D. Glycaemic control among patients with type 2 diabetes
mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management
(RECAP-DM) study. Diabetes Obes Metab. 2008;10:8–15.

29. cCohnatnroJlC: ,TGheaginlitaerrdninaotioJnJ,aBl daiiakbSeHte, sCmhaanntaegloetmJeMn,t Ferrera SR, Hancu N. et al. Multifaceted determinants for achieving glycemic
practice study (IDMPS) Diabetes Care. 2009;32:227–33.

30. Zhu VJ, Tu W, Marrero DG, Rosenman MB, Overhage JM. Race and medication adherence and glycemic control: findings from an
operational health information exchange. AMIA Annu Symp Proc. 2011; 2011:1649–57.

31. Tan MY, Magarey J. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control. Patient Educ Couns.
2008; 72:252–67.

32. Afingednincgys for Healthcare Research and Quality. Disparities in health care quality among racial and ethnic minority groups:
from the national healthcare quality and disparities reports, 2008 [fact sheet]. http://www.ahrq.gov/qual/nhqrdr08/
nhqrdrminority08.htm. Published September 2009. Accessed March 9, 2010.

33. Weeks WB, Wallace AE, West AN, Heady HR, Hawthorne K. Research on rural veterans: an analysis of the literature. J Rural Health.
2008; 24 (4):337-344. 3.